ACPHARIS
Holliston, MA · Biotech · Private
Computational software for predicting B cell epitopes on antigens using protein-protein docking and machine learning algorithms
acpharis.com →- Grants
- $1.9M
- 10 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Design of target-specific libraries for fragment based drug discovery | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Design of target-specific libraries for fragment based drug discovery | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Knowledge-based Extensions of Protein-Protein Docking | $150,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of Structure Based Potential for Protein Mapping | $204,249 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of Structure Based Potential for Protein Mapping | $204,249 | |
| Federal grant | Department of Health and Human Services · Phase I · Software for Antibody Epitope Prediction | $149,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Software for Antibody Epitope Prediction | $149,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Deep learning augmented protein mapping software to screen large compound libraries | $173,006 | |
| Federal grant | Department of Health and Human Services · Phase I · Algorithm and software for predicting the structure and degrading efficiency of PROTACs | $202,274 | |
| Federal grant | Department of Health and Human Services · Phase I · Software for increased accuracy prediction of antibody-antigen complexes | $202,467 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2971 | CANCURE LLC | — | — |
| 2972 | ADMA BIOLOGICS, INC. | — | — |
| 2973 | Loop East Community Improvement District | — | $1.6M |
| 2974 | ACPHARIS | — | — |
| 2975 | INVVAX, INC. | — | — |
| 2976 | CAMBIUM ONCOLOGY LLC | — | — |
| 2977 | MEDICATIONS DISCOVERY TEXAS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.